⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for advanced merkel cell carcinoma

Every month we try and update this database with for advanced merkel cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell CarcinomaNCT03304639
Advanced Merkel...
Clinical Stage ...
Clinical Stage ...
Metastatic Merk...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pembrolizumab
Stereotactic Bo...
18 Years - National Cancer Institute (NCI)
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesNCT04902040
Advanced Bladde...
Advanced Lung N...
Advanced Malign...
Advanced Melano...
Advanced Merkel...
Advanced Renal ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage III Bladd...
Stage III Lung ...
Stage III Renal...
Stage IIIA Blad...
Stage IIIA Lung...
Stage IIIB Blad...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Bladde...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Bladd...
Stage IVA Lung ...
Stage IVB Bladd...
Stage IVB Lung ...
Atezolizumab
Avelumab
Durvalumab
Nivolumab
Pembrolizumab
Plinabulin
Radiation Thera...
18 Years - M.D. Anderson Cancer Center
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesNCT04902040
Advanced Bladde...
Advanced Lung N...
Advanced Malign...
Advanced Melano...
Advanced Merkel...
Advanced Renal ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage III Bladd...
Stage III Lung ...
Stage III Renal...
Stage IIIA Blad...
Stage IIIA Lung...
Stage IIIB Blad...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Bladde...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Bladd...
Stage IVA Lung ...
Stage IVB Bladd...
Stage IVB Lung ...
Atezolizumab
Avelumab
Durvalumab
Nivolumab
Pembrolizumab
Plinabulin
Radiation Thera...
18 Years - M.D. Anderson Cancer Center
Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell CarcinomaNCT03304639
Advanced Merkel...
Clinical Stage ...
Clinical Stage ...
Metastatic Merk...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pembrolizumab
Stereotactic Bo...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: